Release behaviour of carbamazepine-loaded poly(ε-caprolactone)/poly(ethylene oxide) microspheres

References

• Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Rel 2004; 100: 5–28
   PubMed Web of Science ®Google Scholar
• Barakat N, Radwan M. In vitro performance of carbamazepine loaded to various molecular weights of poly(D,L-lactide-co-glycolide). Drug Deliv 2006; 13: 9–18
   PubMed Web of Science ®Google Scholar
• Bei J, Wang W, Wang Z, Wang S. Surface properties and drug release behavior of polycaprolactone polyether blend and copolymer. Polym Adv Technol 1996; 7: 104–7
   Web of Science ®Google Scholar
• Bikiaris D, Papageorgiou GZ, Stergiou A, Pavlidou E, Karavas E, Kanaze F, Georgarakis M. Physicochemical studies on solid dispersions of poorly water-soluble drugs: Evaluation of capabilities and limitations of thermal analysis techniques. Thermochim Acta 2005; 439: 58–67
   Web of Science ®Google Scholar
• Chaturvedi K, Kulkarni AR, Aminabhavi TM. Blend microspheres of poly(3-hydroxybutyrate) and cellulose acetate phthalate for colon delivery of 5-fluorouracil. Ind Eng Chem Res 2011; 50: 10414–23
   Web of Science ®Google Scholar
• Chen D, Chen H, Bei J, Wang S. Morphology and biodegradation of microspheres of polyester-polyether block copolymer based on polycaprolactone/polylactide/poly(ethylene oxide). Polym Int 2000; 49: 269–76
   Google Scholar
• Cleek RL, Ting KC, Eskin SG, Mikos AG. Microparticles of poly(D,L-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery. J Control Rel 1997; 48: 259–68
   Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001; 13: 123–33
   PubMed Web of Science ®Google Scholar
• Dong WY, Maincent P, Bodmeier R. In vitro and in vivo evaluation of carbamazepine-loaded enteric microparticles. Int J Pharm 2007; 331: 84–92
   PubMed Web of Science ®Google Scholar
• Edlund U, Albertsson A. Degradable polymer microspheres for controlled drug delivery. Adv Polym Sci 2002; 157: 67–112
   Web of Science ®Google Scholar
• Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm 2004; 282: 1–18
   PubMed Web of Science ®Google Scholar
• Gref R, Minamitake Y, Peracchia MT, Trubetskoy VS, Trorchilin VP, Langer R. Biodegradable long-circulating polymeric nanospheres. Science 1994; 263: 1600–3
   PubMed Web of Science ®Google Scholar
• Jeong J-C, Lee J, Cho K. Effects of crystalline microstructure on drug release behavior of poly(ε-caprolactone) microspheres. J Control Rel 2003; 92: 249–58
   PubMed Web of Science ®Google Scholar
• Karal-Yilmaz O, Serhatli M, Baysal K, Baysal BM. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique. J Microencapsulation 2011; 28: 46–54
   PubMed Web of Science ®Google Scholar
• Karatas A, Sonakin O, Kilicarslan M, Baykara T. Poly (ε-caprolactone) microparticles containing levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: Effects of some formulation parameters on microparticle characteristics. J Microencapsulation 2009; 26: 63–74
   PubMed Web of Science ®Google Scholar
• Kawaguchi H. Functional polymer microspheres. Prog Polym Sci 2000; 25: 1171–210
   Web of Science ®Google Scholar
• Kim HK, Chung HJ, Park TG. Biodegradable polymeric microspheres with “open/closed” pores for sustained release of human growth hormone. J Control Rel 2006; 112: 167–74
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee HB, Andrade JD. Blood compatibility of polyethylene oxide surfaces. Prog Polym Sci 1995; 20: 1043–79
   Web of Science ®Google Scholar
• Li G, Cai Q, Bei J, Wang S. Relationship between morphology structure and composition of polycaprolactone/poly(ethylene oxide)/polylactide copolymeric microspheres. Polym Adv Technol 2002; 13: 636–43
   Web of Science ®Google Scholar
• Li G, Cai Q, Bei J, Wang S. Morphology and levonorgestrel release behavior of polycaprolactone/poly(ethylene oxide)/polylactide tri-component copolymeric microspheres. Polym Adv Technol 2003; 14: 239–44
   Google Scholar
• Li F, Tian F, Liu C-J, Zhao Y-L. Preparation and characterization of improved microspheres containing bovine serum albumin. J Appl Polym Sci 2009; 114: 818–25
   Web of Science ®Google Scholar
• Lim Soo P, Luo L, Maysinger D, Eisenberg A. Incorporation and release of hydrophobic probes in biocompatible polycaprolactone-block-poly(ethylene oxide) micelles: Implications for drug delivery. Langmuir 2002; 18: 9996–10004
   Web of Science ®Google Scholar
• Lu L, Stamatas GN, Mikos AG. Controlled release of transforming growth factor β1 from biodegradable polymer microparticles. J Biomed Mater Res 2000; 50: 440–51
   PubMed Web of Science ®Google Scholar
• Ma G, Song C. PCL/poloxamer 188 blend microsphere for paclitaxel delivery: Influence of poloxamer 188 on morphology and drug release. J Appl Polym Sci 2007; 104: 1895–9
   Google Scholar
• Moneghini M, Voinovich D, Princivalle F, Magarotto L. Formulation and evaluation of vinylpyrrolidone/vinylacetate copolymer microspheres with carbamazepine. Pharm Dev Technol 2000; 5: 347–53
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J Control Rel 2008; 125: 193–209
   PubMed Web of Science ®Google Scholar
• O’Donnell PB, McGinity JW. Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliv Rev 1997; 28: 25–42
   PubMed Web of Science ®Google Scholar
• Papadimitriou S, Bikiaris D. Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release. J Control Rel 2009; 138: 177–84
   PubMed Web of Science ®Google Scholar
• Park S-J, Kim K-S, Kim S-H. Effect of poly(ethylene oxide) on the release behaviors of poly(ε-caprolactone) microcapsules containing erythromycin. Colloids Surf B 2005; 43: 238–44
   PubMed Web of Science ®Google Scholar
• Pepic DS, Andjelkovic DR, Nikolic MS, Grujic SD, Djonlagic JA. Optimization of preparation conditions of poly(ε-caprolactone) microspheres for controlled release of carbamazepine. Hem Ind 2010; 64: 491–502
   Google Scholar
• Pepic D, Spasojevic M, Nikolic MS, Djonlagic J. Preparation of biodegradable porous poly(butylene succinate) microspheres. Hem Ind 2008; 62: 329–38
   Google Scholar
• Pitt CG. Poly ε-caprolactone and its copolymers. Biodegradable polymers as drug delivery systems, M Casin, R Langer. Marcel Dekker, New York 1990; 71–120
   Google Scholar
• Quaglia F, Ostacolo L, Nese G, De Rosa G, La Rotonda MI, Palumbo R, Maglio G. Microspheres made of poly(ε-caprolactone)-based amphiphilic copolymers: Potential in sustained delivery of proteins. Macromol Biosci 2005; 5: 945–54
   Google Scholar
• Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Rel 1987; 5: 23–36
   Google Scholar
• Rokhade AP, Patil SA, Belhekar AA, Halligudi SB, Aminabhavi TM. Preparation and evaluation of cellulose acetate butyrate and poly(ethylene oxide) blend microspheres for gastroretentive floating delivery of repaglinide. J Appl Polym Sci 2007; 105: 2764–71
   Web of Science ®Google Scholar
• Rudzinski WE, Aminabhavi TM. Chitosan as a carrier for targeted delivery of small interfering RNA. Int J Pharm 2010; 399: 1–11
   PubMed Web of Science ®Google Scholar
• Rustichelli C, Gamberini G, Ferioli V, Gamberini MC, Ficarra R, Tommasini S. Solid-state study of polymorphic drugs: Carbamazepine. J Pharm Biomed Anal 2000; 23: 41–54
   PubMed Web of Science ®Google Scholar
• Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2001; 48: 139–57
   PubMed Web of Science ®Google Scholar
• Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-ε-caprolactone microspheres and nanospheres: An overview. Int J Pharm 2004; 278: 1–23
   PubMed Web of Science ®Google Scholar
• Woodruff MA, Hutmacher DW. The return of a forgotten polymer-Polycaprolactone in the 21st century. Prog Polym Sci 2010; 35: 1217–56
   Web of Science ®Google Scholar
• Yeh M-K, Jenkins PG, Davis SS, Coombes AGA. Improving the delivery capacity of microparticle systems using blends of poly(D,L-lactide-co-glycolide) and poly(ethylene glycol). J Control Rel 1995; 37: 1–9
   Web of Science ®Google Scholar
• Yu G, Zhang Y, Shi X, Li Z, Gan Z. Surface property and in vitro biodegradation of microspheres fabricated by poly(ε-caprolactone-b-ethylene oxide) diblock copolymers. J Biomed Mater Res Part A 2008; 84: 926–39
   Google Scholar
• Zanetti-Ramos B, Soldi M, Soldi V, Lemos-Senna E. The effect of polyethylene glycol on drug content, particle morphology, and carbamazepine release profiles of sustained release microspheres prepared from cellulose acetate butyrate. Acta Farm Bonaerense 2006; 25: 177–83
   Google Scholar
• Zerrouk N, Chemtob C, Arnaud P, Toscani S, Dugue J. In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions. Int J Pharm 2001; 225: 49–62
   PubMed Web of Science ®Google Scholar
• Zhou S, Deng X, Yang H. Biodegradable poly(ε-caprolactone)-poly(ethylene glycol) block copolymers: Characterization and their use as drug carriers for a controlled delivery system. Biomaterials 2003; 24: 3563–70
   PubMed Web of Science ®Google Scholar